Herein is reported the use of an antibody comprising an Fc-region with abolished FcRn binding for the transport of a soluble receptor ligand from the eye over the blood-ocular-barrier into the blood circulation.LA INVENCIÓN PROPORCIONA ANTICUERPOS MODIFICADOS DE UNIÓN A FCRN HUMANO Y MÉTODOS DE UTILIZACIÓN.